Answer
NeoRecormon (epoetin beta) can be administered subcutaneously or intravenously for symptomatic anaemia in adults and children with chronic renal failure, with subcutaneous administration preferred for patients not receiving haemodialysis to avoid puncturing peripheral veins.
Sources for this answer
- Neorecormon Solution for Injection in Pre-Filled SyringeRoche Products Limited · emc · SmPC §4.2 Posology and method of administration · Version 31Document updated
Sources checked